Nicolas Pranno

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens

Philippe L. L’Allier, Grégory Ducrocq, Nicolas Pranno et al. · Journal of the American College of Cardiology · 2008 · 67 citations

Medicine, Pharmacology, Pharmacotherapy +10

The Effect of Bromocriptine on Left Ventricular Functional Recovery in Peripartum Cardiomyopathy: Insights from the BRO-HF Retrospective Cohort Study

Maxime Tremblay‐Gravel, Guillaume Marquis‐Gravel, Robert Avram et al. · ESC Heart Failure · 2018 · 52 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Contemporary incidence and predictors of left ventricular thrombus in patients with anterior acute myocardial infarction

Laurie‐Anne Boivin‐Proulx, Fabrice Ieroncig, Simon-Pierre Demers et al. · Clinical Research in Cardiology · 2023 · 15 citations

Medicine, Cardiology, Internal Medicine +16